New drug combo tested for Tough-to-Treat liver cancer
NCT ID NCT07209813
Summary
This study is testing if adding an experimental drug called GKL-006 to a standard liver cancer treatment (TACE) is more effective and safe. It will involve about 48 adults with advanced liver cancer that cannot be removed by surgery. The main goal is to see if the combination shrinks tumors better than the standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.